Bioaerosols and sick building syndrome: Particles, inflammation, and allergy

Current Opinion in Allergy and Clinical Immunology

Volumn 5, Issue 2, 2005, Pages 135-139

  Laumbach, Robert J ^a   Kipen, Howard M ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Bioaerosols; Building related illness; Inflammation; Sick building syndrome; Stress

Indexed keywords

ALKANE DERIVATIVE; ALKENE DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; KETONE DERIVATIVE; MYCOTOXIN; TERPENE DERIVATIVE; VOLATILE ORGANIC COMPOUND; VOMITOXIN;

AIRBORNE PARTICLE; ALLERGIC RHINITIS; BIOLOGICAL MONITORING; ENVIRONMENTAL EXPOSURE; HUMAN; INFLAMMATION; MICROBIAL CONTAMINATION; MYCOTOXICOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SICK BUILDING SYNDROME; STRESS;

EID: 15944417542     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.all.0000162305.05105.d0     Document Type: Review

References (45)

1. Menzies D, Bourbeau J. Building-related illnesses. N Engl J Med 1997; 337:1524-1531.
2. Spengler JD, Sexton K. Indoor air pollution: a public health perspective. Science 1983; 221:9-17.
3. WHO. Indoor air quality research. Euro Reports and Studies No. 103. Copenhagen: World Health Organization; 1986.
4. Burge PS. Sick building syndrome. Occup Environ Med 2004; 61:185-190. Overview of SBS, citing environmental and psychosocial factors.
5. Fung F, Hughson WG. Health effects of indoor fungal bioaerosol exposure. Appl Occup Environ Hyg 2003; 18:535-544. Review and analysis of evidence for health effects of indoor mold exposure.
6. Hardin BD, Kelman BJ, Saxon A. Adverse human health effects associated with molds in the indoor environment. J Occup Environ Med 2003; 45:470-478. Critical review of basic mechanisms by which fungi can cause health effects (hypersensitivity, infection, and toxicity) and their relevance to indoor mold exposure.
7. Institute of Medicine of the National Academies. Damp indoor spaces and health. Washington, DC: National Academies of Press; 2004. Comprehensive review of the scientific literature regarding possible links between mold, and other factors in damp buildings, and building-related illness and SBS.
8. Terr AI. Are indoor molds causing a new disease? J Allergy Clin Immunol 2004; 113:221-226. A skeptical viewpoint on illness and disease attributed to mold.
9. Kilburn KH. Indoor mold exposure associated with neurobehavioral and pulmonary impairment: a preliminary report. Arch Environ Health 2003; 58:390-398. Along with Refs [10asterisk inside a circle sign,11asterisk inside a circle sign], describes provocative case-series suggesting potential serious disease from indoor mold exposures.
10. Gray MR, Thrasher JD, Crago R, et al. Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged buildings. Arch Environ Health 2003; 58:410-420. Along with Refs [9,asterisk inside a circle sign11asterisk inside a circle sign], describes provocative case-series suggesting potential serious disease from indoor mold exposures.
11. Rea WJ, Didriksen N, Simon TR, et al. Effects of toxic exposure to molds and mycotoxins in building-related illnesses. Arch Environ Health 2003; 58:399-405. Along with Refs [9asterisk inside a circle sign,10asterisk inside a circle sign], describes provocative case-series suggesting potential serious disease from indoor mold exposures.
12. Chapman JA, Terr AI, Jacobs RL, et al. Toxic mold: phantom risk vs science. Ann Allergy Asthma Immunol 2003; 91:222-232. Skeptical review of health effects attributed to mold.
13. Shusterman D, Murphy MA, Balmes J. Differences in nasal irritant sensitivity by age, gender, and allergic rhinitis status. Int Arch Occup Environ Health 2003; 76:577-583. Provides data from controlled human exposure experiments exploring host factors in sensitivity to irritant exposures.
14. Skyberg K, Skulberg KR, Eduard W, et al. Symptoms prevalence among office employees and associations to building characteristics. Indoor Air 2003; 13:246-252. A large survey study providing evidence of increased reporting of nonspecific symptoms among occupants with allergies.
15. Esch RE. Manufacturing and standardizing fungal allergen products. J Allergy Clin Immunol 2004; 113:210-215. Reviews the state of standardization of commercial fungal allergen extracts and implications for mold allergy diagnosis and treatment.
16. Frew AJ. Mold allergy: some progress made, more needed. J Allergy Clin Immunol 2004; 113:216-218.
17. Bholah R, Subratty AH. Indoor biological contaminants and symptoms of sick building syndrome in office buildings in Mauritius. Int J Environ Health Res 2002; 12:93-98.
18. Jarvis JQ, Morey PR. Allergic respiratory disease and fungal remediation in a building in a subtropical climate. Appl Occup Environ Hyg 2001; 16:380-388.
19. Sudakin DL. Toxigenic fungi in a water-damaged building: an intervention study. Am J Ind Med 1998; 34:183-190.
20. Mendell MJ, Naco GM, Wilcox TG, Sieber WK. Environmental risk factors and work-related lower respiratory symptoms in 80 office buildings: an exploratory analysis of NIOSH data. Am J Ind Med 2003; 43:630-641. An informative analysis of a large amount of data from standardized National Institutes of Occupational Safety and Health building investigations that highlights the strengths and limitations of cross-sectional studies of SBS.
21. Chao HJ, Schwartz J, Milton DK, Burge HA. The work environment and workers' health in four large office buildings. Environ Health Perspect 2003; 111:1242-1248. A rigorous longitudinal study of associations between office work environments and health over time, demonstrating the complexity of indoor factors that may affect health and building-related symptoms.
22. Handal G, Leiner MA, Cabrera M, Straus DC. Children symptoms before and after knowing about an indoor fungal contamination. Indoor Air 2004; 14:87-91. An intervention study in which reports of symptoms among school children improved after remediation of mold contamination in the school building.
23. Kennedy SM, Copes R, Bartlett KH, Brauer M. Point-of-sale glass bottle recycling: indoor airborne exposures and symptoms among employees. Occup Environ Med 2004; 61:628-635. A quasi-industrial study of exposures and symptoms among employees breaking and recycling glass bottles in liquor stores that found associations between symptoms and both fungal exposures and psychosocial factors.
24. Heinrich J, Holscher B, Douwes J, et al. Reproducibility of allergen, endotoxin and fungi measurements in the indoor environment. J Expo Anal Environ Epidemiol 2003; 13:152-160. Serial measurements showed high correlations for allergens and endotoxins, but not culturable fungi, in dust samples from a large number of houses.
25. Chew GL, Rogers C, Burge HA, et al. Dustborne and airborne fungal propagules represent a different spectrum of fungi with differing relations to home characteristics. Allergy 2003; 58:13-20. A large, rigorous study finding weak correlations between culturable fungi in dust and short-term air samples in homes, highlighting the need for better understanding of exposure variables and better methods of assessing them.
26. American Industrial Hygiene Association. Field guide for the determination of biological contaminants in environmental samples. Fairfax, VA: AIHA Publications; 1996.
27. Vojdani A, Thrasher JD, Madison RA, et al. Antibodies to molds and satratoxin in individuals exposed in water-damaged buildings. Arch Environ Health 2003; 58:421-432.
28. Patovirta RL, Reiman M, Husman T, et al. Mould specific IgG antibodies connected with sinusitis in teachers of mould damaged school: a two-year follow-up study. Int J Occup Med Environ Health 2003; 16:221-230. A small study finding an association with self-reported sinusitis and IgG to several mold species in school teachers in water-damaged schools, but no association between IgG titers and exposure.
29. Immonen J, Laitinen S, Taskinen T, et al. Mould-specific immunoglobulin G antibodies in students from moisture- and mould-damaged schools: a 3-year follow-up study. Pediatr Allergy Immunol 2002; 13:125-128.
30. Jarvis BB. Analysis for mycotoxins: the chemist's perspective. Arch Environ Health 2003; 58:479-483. A technical review of the state-of-the-art in mycotoxin analysis.
31. Ammann HM. Is indoor mold contamination a threat to health? Part two. J Environ Health 2003; 66:47-49.
32. Meky FA, Turner PC, Ashcroft AE, et al. Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol 2003; 41: 263-273.
33. Wilkins K, Larsen K, Simkus M. Volatile metabolites from mold growth on building materials and synthetic media. Chemosphere 2000; 41:437-446.
34. Husman T. Health effects of indoor-air microorganisms. Scand J Work Environ Health 1996; 22:5-13.
35. Pasanen AL, Korpi A, Kasanen JP, et al. Can microbial volatile metabolites cause irritation at indoor air concentrations? In: Johanning E, editor. Bioaerosols, fungi, and mycotoxins: health effects, assessment, prevention and control. Albany, NY: Eastern New York Occupational and Environmental Health Center; 1999. pp. 60-65.
36. Fan Z, Lioy PJ, Weschler CJ, et al. Ozone-initiated reactions with mixtures of volatile organic compounds under simulated indoor conditions. Environ Sci Technol 2003; 37:1811-1821. Describes experiments in which terpene components of a volatile organic chemical mixture react with low-level ozone to form a potentially irritating secondary organic aerosol under simulated indoor conditions.
37. Wainman T, Zhang J, Weschler CJ, Lioy PJ. Ozone and limonene in indoor air: a source of submicron particle exposure. Environ Health Perspect 2000; 108:1139-1145.
38. Wolkoff P, Clausen PA, Wilkins CK, Nielsen GD. Formation of strong airway irritants in terpene/ozone mixtures. Indoor Air 2000; 10:82-91.
39. Laumbach RJ, Fiedler N, Weschler CJ, et al. Do MVOCs cause irritation?: Nasal effects of VOCs and VOC oxidation products in controlled human exposures. Proceedings of the 5th International Conference on Fungi, Bacteria, Mycotoxins and Human Health (in press).
40. Huttunen K, Hyvarinen A, Nevalainen A, et al. Production of proinflammatory mediators by indoor air bacteria and fungal spores in mouse and human cell lines. Environ Health Perspect 2003; 111:85-92. Interesting comparison of relative in-vitro toxicity of several species of bacteria and fungi.
41. Jussila J, Komulainen H, Huttunen K, et al. Inflammatory responses in mice after intratracheal instillation of spores of Streptomyces californicus isolated from indoor air of a moldy building. Toxicol Appl Pharmacol 2002; 171:61-69.
42. Jussila J, Pelkonen J, Kosma VM, et al. Systemic immunoresponses in mice after repeated exposure of lungs to spores of Streptomyces californicus. Clin Diagn Lab Immunol 2003; 10:30-37. Study demonstrating systemic immune system effects, of uncertain clinical significance, in mice exposed to spores of S. Californicus.
43. Korpi A, Kasanen JP, Raunio P, Pasanen AL. Acute effects of Aspergillus versicolor aerosols on murine airways. Indoor Air 2003; 13:260-266.
44. Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998; 105:83-107.
45. Weinhold B. Environmental cardiology: getting to the heart of the matter. Environ Health Perspect 2004; 112:A880-A887.